Cargando…
CLEAR Strategy Inhibited HSV Proliferation Using Viral Vectors Delivered CRISPR-Cas9
Herpes simplex virus type 1 (HSV-1) is a leading cause of encephalitis and infectious blindness. The commonly used clinical therapeutic drugs are nucleoside analogues such as acyclovir. However, current drugs for HSV cannot eliminate the latent virus or viral reactivation. Therefore, the development...
Autores principales: | Ying, Min, Wang, Huadong, Liu, Tongtan, Han, Zengpeng, Lin, Kunzhang, Shi, Qing, Zheng, Ning, Ye, Tao, Gong, Huinan, Xu, Fuqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302303/ https://www.ncbi.nlm.nih.gov/pubmed/37375504 http://dx.doi.org/10.3390/pathogens12060814 |
Ejemplares similares
-
A Recombinant Baculovirus Efficiently Generates Recombinant Adeno-Associated Virus Vectors in Cultured Insect Cells and Larvae
por: Wu, Yang, et al.
Publicado: (2018) -
High-brightness anterograde transneuronal HSV1 H129 tracer modified using a Trojan horse-like strategy
por: Su, Peng, et al.
Publicado: (2020) -
The CRISPR/Cas9 System Delivered by Extracellular Vesicles
por: Zhu, Xinglong, et al.
Publicado: (2023) -
Method for Dual Viral Vector Mediated CRISPR-Cas9 Gene Disruption in Primary Human Endothelial Cells
por: Gong, Haixia, et al.
Publicado: (2017) -
CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes
por: Ehrke-Schulz, Eric, et al.
Publicado: (2017)